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Abstract When double-strand breaks (DSBs) in DNA
remain unrepaired, catastrophic loss of genes occurs,
leading to translocations, mutations and carcinogenesis. If
a sister chromatid is not available at the DNA DSB, non-
homologous end joining (NHEJ) is used to join broken
ends. The NHEJ pathway comprises synapsis, end pro-
cessing and ligation. Here, we ask how DSBs in DNA are
repaired efficiently. We suggest that colocation of proteins
is achieved over time by the following components: stages,
where the main actors are assembled, scaffolds that are
erected quickly around broken parts to give access, and
strings that tether proteins together. In NHEJ, a stage is
provided by the Ku heterodimer interacting with DSBs and
several other proteins including DNA-PKcs, APLF,
BRCA1 and PAXX. A further stage, DNA-PKcs, links the
kinase with DNA, Ku, PARP1, BRCA1 and Artemis. A
temporary scaffold facilitates repair and is constructed
from XRCC4/XLF filaments that bridge Ku bound at DSB
ends. LigIV bound to XRCC4 C-termini likely terminates
the scaffold, bringing LigIV close to the DNA broken ends.
A string, provided by the Artemis C-terminal region, is
intrinsically disordered but includes short linear ‘‘epitopes’’
that recognise DNA-PKcs, LigIV and PTIP, so keeping
these components nearby. We show that these stages,
scaffolds and strings facilitate colocation and efficient DSB
repair. Understanding these processes provides insight into
the biology of DNA repair and possible therapeutic inter-
vention in cancer and other diseases.
Keywords Non-homologous end joining  DNA repair 
DNA-PKcs  XRCC4  Artemis  Protein–protein
interactions
Introduction
DNA double-strand breaks (DSBs) are the most severe form
of DNA damage in eukaryotic cells and are generated by
ionising radiation, reactive oxygen species and DNA repli-
cation across nicks [1]. DSBs can lead to cell death, and
erroneous repair may result in carcinogenesis through
chromosomal translocation or modification. Non-homolo-
gous end joining (NHEJ) and homologous recombination
(HR) are the two major pathways of DSB repair in human
cells. HR functions mainly in the late S/G2 phases of the cell
cycle due to the requirement for a sister chromatid. In
contrast, NHEJ repairs DSBs directly without a DNA tem-
plate and can function throughout G1/early S phases [1].
The NHEJ process comprises DNA synapsis, end pro-
cessing and ligation [2]. During synapsis, Ku70/Ku80
heterodimers assemble around and maintain proximity of
broken DNA ends [3]. DNA-dependent protein kinase
catalytic subunit (DNA-PKcs), a PI3-kinase-related kinase,
is recruited through interaction with the Ku80 C-terminus
to form DNA-PK [4, 5]. Two DNA-PK complexes are
thought to hold DNA ends close together [6]. DNA-PKcs
phosphorylates itself and various other proteins, including
NHEJ components. End processing involves nucleases
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such as Artemis, which exhibits endonuclease activity after
activation by DNA-PKcs phosphorylation [7]. The final
ligation step is mediated by DNA ligase IV (LigIV) in a
stable complex with dimeric XRCC4 [8]. XLF/Cernunnos
also interacts with XRCC4 and enhances LigIV DNA
ligation, promoting NHEJ [9, 10].
Structural and functional studies of individual compo-
nents in NHEJ previously reported include DNA-PKcs
[11], LigIV [12], XLF [13] and XRCC4 [14]. We have
investigated the following binary complexes: LigIV/
XRCC4 [14], XRCC4/XLF [15], LigIV/Artemis [16] and
DNA-PKcs/Ku80 C-terminus [11; Sibanda BL, Chirgadze
DY, Ascher D, Blundell TL, In preparation]. Last year we
discovered PAXX [17], an additional component involved
in NHEJ (Fig. 1).
These studies and others (e.g. [18, 19]) still leave
unanswered questions, including how NHEJ components
are coordinated across space and time throughout synapsis,
end processing and ligation. We observed three different
mechanisms that may ensure appropriate spatial colocation
of components: stages that are preformed stable structures
where the main actors gather and engage, scaffolds that are
constructed quickly and disassembled easily to facilitate
cell responses, and strings that tether components together.
For NHEJ, these include:
1. A stage comprised of Ku heterodimer, interacting with
DNA broken ends and binding a variety of components
including DNA-PKcs, aprataxin- and PNKP-like factor
(APLF), XLF, BRCA1 and PAXX.
2. A further stage, DNA-PKcs, which interacts with Ku
heterodimer, DNA, PARP1, BRCA1, Artemis and
other components, often depending on post-transla-
tional modification and binding of other factors.
3. A scaffold assembled from protein filaments of alter-
nating XRCC4 and XLF dimers to bridge Ku
heterodimers. This bridging is regulated by LigIV,
which the tails of XRCC4 bind tightly, therefore
bringing LigIV close to DNA broken ends.
4. An intrinsically disordered string comprising the
300-residue C-terminal region of Artemis. Foldable
regions of the Artemis C-terminus interact with DNA-
PKcs, LigIV and PTIP, which may keep these com-
ponents close to the DNA repair process in order to be
available to function when needed.
Apart from ensuring correct colocation at the appropriate
time, we have contended that the complexity of such
assemblies is selectively advantageous [20–22]. Binary
interactions in regulatory or signalling systems would
occur opportunistically in the crowded environment of the
cell, giving rise to noise in the system. Conversely, coop-
erative formation of multiprotein systems is less likely to
form opportunistically, especially if they have many
components and ordered-assembly mechanisms.
Here, we show that such stages, scaffolds and strings
have complementary roles, often binding to the same
partners but operating in different ways over space and
time. Understanding spatial and temporal organisation of
NHEJ may provide insight into whether such mechanisms
are universal for mediating colocation in other complex
regulatory systems.
Assembling and coordinating the actors in NHEJ
Spatial organisation of molecular assemblies in NHEJ has
been studied using nanoelectrospray mass spectrometry,
small-angle X-ray scattering (SAXS), X-ray crystallogra-
phy, NMR and cryo-electron microscopy (cryo-EM).
Cumulative insight from these techniques allows us to
understand further how NHEJ proceeds efficiently over
time.
A stage: Ku heterodimer forms a platform
with DNA
The Ku heterodimer assembles around broken DNA ends,
forming a stage in which the core ring structure is
responsible for interacting with APLF, WRN, XLF, PAXX
and BRCA1, and the C-terminal domain of Ku80 interacts
with DNA-PKcs [4, 5, 23]. We are using X-ray crystal-
structure analysis, cryo-EM and biophysical approaches to
define the interactions between components and describe
the subsequent structural changes. We comment here on
two of the proteins that assemble on this stage and whose
interactions have been topics of recent discussion.
PAXX, identified recently in our lab as PAralog of
XRCC4 and XLF by using structure-based homology
Fig. 1 NHEJ protein network. Arrows indicate a known interaction.
Blue labels indicate the structure has been determined. Green arrows
indicate complexes with experimentally defined structural interac-
tions (Color figure online)
Struct Chem
123
searches, interacts with Ku to promote DNA-DSB repair
[17, 24, 25] (Fig. 2). Using an in vitro pull-down assay and
biochemical analysis, we showed that the PAXX C-termi-
nus (residues 177–204) interacts with the core ring of Ku in
a DNA-dependent manner. We suggested this interaction
might be regulated by phosphorylation of the PAXX
C-terminus by DNA-PK. In collaboration with the labora-
tory of Dr. Steve Jackson [17], we demonstrated that
PAXX is recruited to DNA-damage sites in cells, and
PAXX depletion leads to DSB-repair defects and hyper-
sensitivity to ionising radiation. Using RNA interference
and CRISPR-Cas9 to generate PAXX-/- human cells, we
showed that PAXX functions with XRCC4 and XLF to
mediate DSB repair and cell survival in response to DSB-
inducing agents. PAXX promotes Ku-dependent DNA
ligation in vitro and assembly of core non-homologous
end-joining (NHEJ) components on damaged chromatin in
cells.
Two groups have reported an interaction between
BRCA1 and Ku [26, 27]. BRCA1 functions as a tumour
suppresser gene, and patients carrying the germline or
somatic mutations have high risk of developing breast and
ovarian cancer [28]. The expression and phosphorylation of
BRCA1 is cell cycle-dependent with the highest level at
S and M phases [29]. BRCA1 recruitment is important for
influencing Ku70/80 retention at the DNA-damage sites
and promoting the chromosomal G1 phase of NHEJ. The
exact region in BRCA1 responsible for this interaction with
Ku was reported as amino acids 1–200 in one report [27]
but more recently as 262–552 in the other [26]. Our
ongoing objective is to define the region of BRCA1
responsible for the interaction with Ku.
A second stage: DNA-PKcs
In 2010, we described the crystal structure of the *4000
amino-acid chain of DNA-PKcs complexed with the
C-terminus of Ku80 at low resolution, in which the two
molecules in the asymmetric unit have slightly different
relative positions of the head domain and the large circular
structure of HEAT repeats that comprise the stage [11].
More recently, we extended the study to a higher resolu-
tion, allowing the chain to be traced. We are using both
X-ray crystallography and cryo-EM to define how other
molecules, such as Ku and DNA, assemble on this stage.
Interestingly, in the S phase, BRCT domains of BRCA1
(see ‘‘The strings’’ section) are reported to interact with
DNA-PKcs (near S2056) in a phosphorylation-independent
manner to block DNA-PKcs autophosphorylation, reducing
NHEJ and increasing HR [30].
A scaffold: XRCC4/XLF filaments
XRCC4 and XLF are both homodimers with similar
architectures, including the N-terminal head domains and
C-terminal tail regions [13, 14]. Our group [12, 15] and
others [31–35] have shown by mutagenesis study, size
chromatography, SAXS, native mass spectrometry and
X-ray crystallography that XRCC4 and XLF dimers
interact through their head domains, leading to the for-
mation of XRCC4/XLF filaments, elongation of which is
regulated by LigIV [12]. The alternating XRCC4/XLF
helical polymers are flexible, and multiple copies of fila-
ment can assemble into cylinders with a diameter that may
accommodate and colocate other components of NHEJ
(Fig. 3). As a result, XRCC4/XLF filaments may function
as a scaffold to allow the alignment of the two broken DNA
ends and the local assembly of NHEJ components to
enhance LigIV function.
The strings
Artemis C-terminal region
Artemis, which belongs to the metallo-b-lactamase super-
family, is the major nuclease involved in the end-pro-
cessing step of NHEJ. It has been estimated that Artemis
repairs 10–15 % of DSBs generated by IR [36]. The
Artemis gene DCLRE1C was first discovered mutated in
patients who had radiosensitive-severe combined immun-
odeficiency (RS-SCID) and Athabascan SCID (SCIDA)
[7]. It was later found that Artemis is the essential
endonuclease that opens the hairpin intermediate structure
upon stimulation by DNA-PKcs during V(D)J recombina-
tion [37]. The nuclease also has intrinsic 50 exonuclease
activity [38] and weak endonuclease activity on ssDNA
Fig. 2 Structure of PAXX. The crystal structure of PAXX homod-
imer (PDB code: 3WTD) is presented using a cartoon representation.
One of the chains is indicated by rainbow colour; the N- and
C-termini are blue and red, respectively (Color figure online)
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in vitro, which is likely stimulated when forming a com-
plex with DNA-PKcs [39].
The Artemis structure can be divided into two regions,
each accounting for approximately half of its size (Fig. 4).
These regions correspond to the N-terminal nuclease,
adopting b-metallo-lactamase and b-CASP domains [40]
homologous to RNaseJ, Apollo and SNM1A, and a C-ter-
minal region, which has no enzyme activity but is never-
theless indispensable for normal Artemis function [41].
IUPRED (Prediction of Intrinsically Unstructured Proteins)
[42] predicts the C-terminal region of Artemis to be mostly
intrinsically disordered, and ANCHOR (Prediction of
Protein Binding Regions in Disordered Proteins) [43]
analysis predicts several short regions within the intrinsi-
cally disordered C-terminal region to bind globular or
structured protein partners (Fig. 5).
Fig. 3 XRCC4 and XLF. In our crystal structure, alternating
XRCC4/XLF helical polymers can assemble into cylinders with
diameters that may accommodate and colocate other components of
NHEJ (PDB ID: 3W03). a XLF and XRCC4 dimers interact through
their head domains to form a helical XRCC4/XLF filament. b The
filaments assemble as a cylinder in the crystal structure. The view
perpendicular to the filament axis is shown with a single filament.
c The central space created by the filament could potentially
accommodate nucleosome, Ku and DNA-PKcs
Fig. 4 Schematic of the structure of Artemis: the nuclease in the
N-terminal region and the intrinsically disordered C-terminal region.
Artemis recognises other NHEJ components including DNA-PKcs
and LigIV via the indicated regions that undergo concerted folding
and binding
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We previously showed that Artemis residues 485–495
undergo concerted folding and binding with the first two
helices of LigIV to form a three-helix bundle (Fig. 6).
Residue W489 of Artemis forms a hydrogen bond with
D18 of LigIV, stabilised by interactions between F492/
F493 of Artemis and F49/F42 of LigIV. Moreover, P487 of
Artemis resides in the hydrophobic pocket formed by L53,
A52 and F49 of LigIV [16].
Although Artemis was predicted to interact with DNA-
PKcs via residues 399–404 [44], recent pull-down results
from our group show that residues 399–404 are not suffi-
cient. While peptides containing residues 399–408 and
399–426 of Artemis could not pull down DNA-PKcs,
residues 385–413 of Artemis could do so, and even showed
a stronger interaction with DNA-PKcs compared to full-
length Artemis, indicating that residues that are N-terminal
Fig. 5 IUPred and ANCHOR analysis of Artemis with sequence
alignment. The C-terminal region of Artemis is predicted to be
extensively intrinsically disordered according to IUPred. ANCHOR
analysis shows that within the intrinsically disordered region, several
segments are likely to interact with other proteins. Sequence
alignment also shows that many of these segments are conserved
Fig. 6 Interaction between
LigIV and Artemis. The crystal
structure of the catalytic
domains of LigIV (orange) and
the Artemis fragment (amino-
acid residues 485–495; silver) is
shown on the left. The
interaction of the first two
helices of LigIV with Artemis is
shown in close view on the right
(Color figure online)
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to 399–404 are needed for the Artemis/DNA-PKcs inter-
action. Furthermore, residues 641–660 of Artemis may
bind to the second BRCT domain of an adaptor protein,
PTIP, via phosphorylation [43].
Thus, it is likely that the Artemis C-terminus binds to
several key components, including DNA-PKcs, LigIV and
PTIP [45], facilitating colocation of these components with
broken DNA ends. The list may be longer since other
studies reveal that the Artemis C-terminal region interacts
with other proteins. For example, it was shown that Arte-
mis binds to the Mre11/Rad50/Nbs1 complex (MRN
complex) in an ATM-dependent manner under ionising
radiation [46]. Although the precise binding region is not
defined, it is likely that the Artemis C-terminus is involved
given that hyperphosphorylation of Artemis, especially
S645 of the SQ/TQ site on the C-terminal region, is
dependent on ATM. Additionally, Artemis was co-im-
munoprecipitated with Nbs1, and Nbs1/Mre11 were co-
immunoprecipitated with Artemis reciprocally [46].
APLF
APLF (Aprataxin- and-PNK-Like Factor) similarly
includes multiple binding sites throughout the protein,
which facilitate its function both as a stabiliser for the
NHEJ holo-complex at DNA-damage sites and as a stim-
ulator of DNA-end ligation [23, 47]. The N-terminal FHA
domain of APLF interacts with XRCC4 in a phosphory-
lation-dependent manner [48]. The amino acid sequence of
a large region of APLF in between the structured N- and
C-terminal regions is predicted to be intrinsically disor-
dered and is poorly conserved in evolution (Fig. 7).
However, a short sequence (residues 182–192) in this
region is conserved in evolution from the sponge (Am-
phimedon queenslandica) to human. This conserved
sequence is important for the interaction with Ku
[23, 49–51], likely through concerted folding and binding.
Consequently, this binding site within the intrinsically
disordered region of APLF facilitates colocation of the Ku
heterodimer with regions of APLF that have globular
structures.
BRCA1
BRCA1 contains 1863 residues with the two most con-
served domains in BRCA1 located at the N- and C-termini.
The N-terminal RING domain, which forms a heterodimer
with another RING domain from BARD1 [52], functions as
an E3 ubiquitin ligase [53, 54]. The N-terminal region
(1–304) was also recently found to bind the protein OLA1
during centrosome regulation [55]. The C-terminal region
of BRCA1 contains tandem BRCT domains, which appear
to bind DNA-PKcs in a non-phosphorylation-dependent
manner, as discussed above, and also bind phosphopeptides
containing the pSXXF motif [56–58]. We recently deter-
mined the structure of the complex of BRCA1 with the
C-terminal phosphopeptide of Abraxas (Fig. 8) [59].
Abraxas is part of BRCA1-A complex facilitating the
recruitment of BRCA1 to the DNA-damaged site. In col-
laboration with Dr. Bin Wang (MD Anderson Cancer
Center, Houston, TX), we demonstrated that ionising-ra-
diation-induced and ATM-dependent phosphorylation of a
serine residue of Abraxas next to the pSPxF motif induces
dimerisation of the BRCT/Abraxas complex. Mutation of
the ionising-radiation-induced phosphorylation site of
Abraxas leads to a deficiency in BRCA1 accumulation and
cellular sensitivity to ionising radiation. These findings
suggest a novel role of the BRCT/Abraxas complex in the
DNA-damage response [46].
Protein interactions within the N-terminal and C-termi-
nal domains of BRCA1 facilitate its role in the DNA-
damage response and DNA repair, while the long and less
conserved flexible region between these domains provides
additional sites for more dynamic and regulated protein
interactions (Fig. 9). This disordered region contains the
nuclear localisation signal (NLS; amino-acid residues
500–508) [60], PALB-interaction site (amino-acid residues
1397–1424) [61, 62] and phosphorylation sites that are
targeted by ATM, Chk2, Cdk2 and DNA-PK at different
phases of the cell cycle [63–67]. Although the function of
these phosphorylation events is not understood completely,
key phosphorylation events include the following: S1423 is
phosphorylated by ATM for check-point G2/M function
[66], and S988 is phosphorylated by Chk2 [65] for release
from Chk2 and HR activity [65, 68]. Thus, the flexible
inter-domain region of BRCA1 functions as a string to
tether proteins for use as needed.
Discussion
In order for NHEJ to function accurately, spatial and
temporal organisation of NHEJ proteins should be as effi-
cient as possible. This is achieved by colocation of com-
ponents through macromolecular stages, scaffolds and
strings. Despite efforts to understand the spatial assembly
of NHEJ complexes by observing their structures, the exact
coordination of NHEJ proteins at a DSB site remains
unclear. This is due to the dynamic and complex nature of
NHEJ proteins, which should gather in a DSB-dependent
manner and also disassemble quickly after DNA damage is
repaired. Therefore, many NHEJ protein–protein interac-
tions are weak or require the presence of DNA. Moreover,
the proteins may assemble differently depending on the
type of DNA damage. To observe such a flexible and
dynamic biological system, we need to design DNA
Struct Chem
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structures that we would like to study, ‘‘freeze’’ interme-
diate states of the NHEJ process, for instance, using
mutations or crosslinking, and sort heterogeneous samples
according to structural state. These are extremely
challenging tasks for X-ray crystallography. However,
recent advances in cryo-EM offer an attractive approach to
overcome these difficulties.
Nevertheless, the spatial organisation of NHEJ com-
plexes is better understood than the temporal organisation
of NHEJ. Varying models for NHEJ recruitment have been
proposed, and our view is that NHEJ is not a pre-pro-
grammed process, though it does require the sequential
recruitment of stages, scaffolds and strings. The scaffold
proteins may have multiple weak interactions with the
stage proteins, therefore permitting stabilisation of the
scaffolds only when the complete stage is assembled.
Alternatively, the interactions may be regulated through
allostery involving conformational change; DNA-PKcs
conformational changes appear to be activated by post-
translational modification, including auto-phosphorylation.
To study the temporal organisation of NHEJ proteins, it
will be necessary to exploit single-molecule approaches.
Indeed, the synapsis by core NHEJ proteins [69] and a
dynamic nature of the filament formation of XRCC4 and
XLF, which are hard to be visualised by current structural
Fig. 7 Domain and interaction sites of APLF. Crystal structures of the FHA domain [48] and PAR-binding zinc-finger (PBZ) [74] of APLF are
shown. The Ku-interaction region with sequence alignment is indicated, along with other potential interaction regions predicted by Anchor [75]
Fig. 8 Dimerisation of two BRCT/Abraxas complexes. The surface
representation of two BRCT/Abraxas complexes is shown in pink and
blue, respectively (PDB code: 4Y18). The motif-interaction site,
which contains phosphorylated S406 (pS406), is indicated by the
circle formed from a dashed line. Phosphorylation at S404 is
indicated as pS404 (Color figure online)
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techniques, have been investigated by those approaches
[70, 71]. In combination with structural studies of NHEJ
complexes, single-molecule approaches may reveal how
NHEJ proteins are recruited to DSB sites. However, one of
the pitfalls of such in vitro approaches is the assumption
that all NHEJ proteins are known. The discovery of PAXX
in the past 2 years underlines the possibility that there are
components of NHEJ that remain unknown.
Apart from advancing our knowledge of this important
DNA DSB-repair system, understanding the interactions of
NHEJ components across space and time will indicate
novel druggable targets for therapeutic intervention in
cancer and a number of rare genetic diseases. Linear
foldable regions within intrinsically disordered polypep-
tides bind to ligandable sites with well-defined pockets
[72, 73]. In HR, we have exploited this feature by using
fragment-based design to target Rad51-BRCA2 and
develop nanomolar drug candidates [73]. We continue to
explore the ligandability of Artemis-LigIV and other
interactions mediated by the intrinsically disordered
C-terminus of Artemis (Esswein SE, Ochi T and Blundell
TL, unpublished).
Our research not only sheds light on the spatial and tem-
poral organisation of NHEJ, but also invites speculation as to
whether similar stages, scaffolds and strings operate in other
complex regulatory systems. The existence of many globular
proteins or complexes that bind to multiple components
(stages), systems that assemble to form rods and other cell
structural elements (scaffolds), and areas of concerted folding
and binding within intrinsically disordered regions that
facilitate colocation of other globular proteins (strings) sug-
gest that our model may be generic. If so, defining these
properties will further explain how other multicomponent
complexes are coordinated across space and time in cells and
also guide future efforts to regulate these pathways. Such
regulationmay be possible throughmodulation of component
colocation, particularly by targeting the sites where intrinsi-
cally disordered regions interact with globular proteins.
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RING BRCT domains
PALB2 interaction site
(residues 1397-1424)
(P. S. Brzovic et al. 2001).
(R. S. Williams et al. 2001).
Fig. 9 Domains and interaction sites of BRCA1. The protein
sequence alignment and crystal structures of the RING domain [76]
and tandem BRCT domains [77] of BRCA1 are shown. The PALB2
interaction region is indicated, along with other potential interaction
regions predicted by Anchor [75]
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